Caribou Coffee (Nasdaq: CBOU) reported earnings on Nov. 8. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Caribou Coffee beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue dropped and GAAP earnings per share contracted.

Gross margins increased, operating margins expanded, net margins were steady.

Revenue details
 Caribou Coffee notched revenue of $77.2 million. The seven analysts polled by S&P Capital IQ predicted a top line of $75.2 million on the same basis. GAAP reported sales were 5.2% lower than the prior-year quarter's $81.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.08. The six earnings estimates compiled by S&P Capital IQ predicted $0.06 per share. GAAP EPS of $0.08 for Q3 were 11% lower than the prior-year quarter's $0.09 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 17.4%, 120 basis points better than the prior-year quarter. Operating margin was 3.6%, 20 basis points better than the prior-year quarter. Net margin was 2.2%, about the same as the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $89.5 million. On the bottom line, the average EPS estimate is $0.19.

Next year's average estimate for revenue is $326.1 million. The average EPS estimate is $0.44.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 175 members out of 242 rating the stock outperform, and 67 members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 34 give Caribou Coffee a green thumbs-up, and 21 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Caribou Coffee is buy, with an average price target of $15.50.